RBCK1 can regulate ERalpha-positive breast cancer cell cycle progression and proliferation by supporting transcription of ERalpha and cyclin B1 (45), and could be a predictive marker of response to endocrine therapy in breast cancer (46). This evidence concerns the gene RBCK1 and breast carcinoma.